Literature DB >> 21616145

Function of the asparagine 74 residue of the inhibitory γ-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo.

Stephen H Tsang1, Michael L Woodruff, Chun Wei Hsu, Matthew C Naumann, Marianne Cilluffo, Joaquin Tosi, Chyuan-Sheng Lin.   

Abstract

The inhibitory subunit of rod cyclic guanosine monophosphate (cGMP) phosphodiesterase, PDE6γ, is a major component of rod transduction and is required to support photoreceptor integrity. The N74A allele of PDE6γ has previously been shown in experiments carried out in vitro to reduce the regulatory inhibition on the PDE6 catalytic core subunits, PDE6αβ. This should, in intact rods, lead to an increase in basal (dark) PDE6 activity producing a state equivalent to light adaptation in the rods and we have examined this possibility using ERG and suction-electrode measurements. The murine opsin promoter was used to drive the expression of a mutant N74A and a wild-type PDE6γ control transgene in the photoreceptors of +/Pde6g(tm1) mice. This transgenic line was crossed with Pde6g(tm1)/Pde6g(tm1) mice to generate animals able to synthesize only the transgenic mutant PDE6γ. We find that the N74A mutation did not produce a significant decrease in circulating current, a decrease in sensitivity or affect the kinetics of the light response, all hallmarks of the light-adapted state. In an in vitro assay of the PDE purified from the N74A transgenic mice and control mice we could find no increase in basal activity of the mutant PDE6. Both the results from the physiology and the biochemistry experiments are consistent with the interpretation that the mutation causes a much milder phenotype in vivo than was predicted from observations made using a cell-free assay system. The in vivo regulation of PDE6γ on PDE6αβ may be more dynamic and context-dependent than was replicated in vitro.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21616145      PMCID: PMC3148328          DOI: 10.1016/j.cellsig.2011.05.007

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  23 in total

1.  Structural determinants of the PDE6 GAF A domain for binding the inhibitory gamma-subunit and noncatalytic cGMP.

Authors:  Hakim Muradov; Kimberly K Boyd; Nikolai O Artemyev
Journal:  Vision Res       Date:  2004       Impact factor: 1.886

2.  Tissue-specific and developmental regulation of rod opsin chimeric genes in transgenic mice.

Authors:  J Lem; M L Applebury; J D Falk; J G Flannery; M I Simon
Journal:  Neuron       Date:  1991-02       Impact factor: 17.173

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Light-regulated binding of proteins to photoreceptor membranes and its use for the purification of several rod cell proteins.

Authors:  H Kühn
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Gamma-subunit of mouse retinal cyclic-GMP phosphodiesterase: cDNA and corresponding amino acid sequence.

Authors:  N Tuteja; D B Farber
Journal:  FEBS Lett       Date:  1988-05-09       Impact factor: 4.124

6.  A conformational switch in the inhibitory gamma-subunit of PDE6 upon enzyme activation by transducin.

Authors:  A E Granovsky; N O Artemyev
Journal:  Biochemistry       Date:  2001-11-06       Impact factor: 3.162

7.  Channel modulation and the mechanism of light adaptation in mouse rods.

Authors:  Jeannie Chen; Michael L Woodruff; Tian Wang; Francis A Concepcion; Daniel Tranchina; Gordon L Fain
Journal:  J Neurosci       Date:  2010-12-01       Impact factor: 6.167

8.  Early steps in the light-triggered activation of the cyclic GMP enzymatic pathway in rod photoreceptors.

Authors:  H Kühn
Journal:  Prog Clin Biol Res       Date:  1984

9.  Recessive mutations in the gene encoding the beta-subunit of rod phosphodiesterase in patients with retinitis pigmentosa.

Authors:  M E McLaughlin; M A Sandberg; E L Berson; T P Dryja
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

10.  Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse.

Authors:  S J Pittler; W Baehr
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more
  5 in total

1.  Enhanced mitochondrial inhibition by 3,4-dihydroxyphenyl-acetaldehyde (DOPAL)-oligomerized α-synuclein.

Authors:  Theodore A Sarafian; Amneh Yacoub; Anastasia Kunz; Burkan Aranki; Grigor Serobyan; Whitaker Cohn; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2019-08-16       Impact factor: 4.164

2.  Silencing of tuberin enhances photoreceptor survival and function in a preclinical model of retinitis pigmentosa (an american ophthalmological society thesis).

Authors:  Stephen H Tsang; Lawrence Chan; Yi-Ting Tsai; Wen-Hsuan Wu; Chun-Wei Hsu; Jin Yang; Joaquin Tosi; Katherine J Wert; Richard J Davis; Vinit B Mahajan
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

3.  Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α-synuclein.

Authors:  Theodore A Sarafian; Kaitlyn Littlejohn; Sarah Yuan; Charlene Fernandez; Marianne Cilluffo; Bon-Kyung Koo; Julian P Whitelegge; Joseph B Watson
Journal:  J Neurosci Res       Date:  2017-01-24       Impact factor: 4.164

4.  The integrity and organization of the human AIPL1 functional domains is critical for its role as a HSP90-dependent co-chaperone for rod PDE6.

Authors:  Almudena Sacristan-Reviriego; James Bellingham; Chrisostomos Prodromou; Annika N Boehm; Neruban Kumaran; James Bainbridge; Michel Michaelides; Jacqueline van der Spuy
Journal:  Hum Mol Genet       Date:  2017-11-15       Impact factor: 6.150

Review 5.  Photoreceptor Phosphodiesterase (PDE6): Structure, Regulatory Mechanisms, and Implications for Treatment of Retinal Diseases.

Authors:  Rick H Cote; Richa Gupta; Michael J Irwin; Xin Wang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.